iRegene Therapeutics
PrivateLast Round
Series C
Jul 2, 2026
Total Funding Raised
$123.7M
Company Overview
iRegene Therapeutics is a biotechnology company that develops chemically induced allogeneic cell therapies for the treatment of degenerative diseases such as Parkinson's disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
iRegene Therapeutics Comps
Public and private peers based on sector, stage, and business model.
iRegene Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jul 2, 2026 | ||||
| Series C | Jun 1, 2026 | ||||
| Series B Extension | Sep 4, 2025 | ||||
| Series B Extension | Apr 11, 2025 | ||||
| Series B | Oct 14, 2024 | ||||
Series A | Jan 24, 2022 |
iRegene Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ceyuan Ventures | Series B |
| China Capital Management Co., Ltd. | Series C |
| Shenzhen New Industry Venture Capital | VC Round |
| Northern Light Venture Capital | Series B Extension |
| Hony Capital | Series C |
| Shenzhen Dachen Caizhi Venture Capital Management | Series A |
| Wuxi Capital Group Co.,Ltd | Series C |
iRegene Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about iRegene Therapeutics's valuation, stock price, and market status.
